Emami Interim Dividend of ₹4 Record Date Tomorrow, February 4, 2025

Emami Limited’s Board of Directors has declared and approved an interim dividend of ₹4 per equity share of face value ₹1 each.

On February 3, 2025, Emami share price opened at ₹615.05, down from its previous close of ₹625.80. At 9:38 AM, the share price of Emami was trading at ₹614.70, down by 1.77% on the NSE.

Emami Dividend Record Date

On January 27, 2025, the company announced that the Board of Directors declared a 2nd Interim Dividend of ₹4 per fully paid-up equity share of face value ₹1 each (400%) on 43,65,00,000 equity shares for the Financial Year 2024-25. The record date to determine eligible members for receiving the interim dividend is Tuesday, February 4, 2025.

Q3 FY 2025 Financial Highlights

The company’s revenue from operations for the quarter stood at ₹1,049 crore, representing a 5% growth. The core domestic business saw a 9% increase, driven by a 6% growth in volumes. Gross margins improved by 150 basis points, reaching 70.3%, reflecting positive operational efficiency. EBITDA for the quarter was ₹339 crore, up by 8%. The EBITDA margin increased by 70 basis points, standing at 32.3%, showcasing enhanced profitability. Profit After Tax (PAT) grew by 8%, reaching ₹279 crore.

About Emami Ltd

Emami Ltd is a prominent FMCG company in India, specialising in the manufacturing and marketing of personal care and healthcare products. The company boasts a diverse portfolio of over 550 products, including renowned brands such as Navratna, BoroPlus, Fair & Handsome, Zandu Balm, Mentho Plus, and Kesh King. Emami expanded its footprint by acquiring Zandu Pharmaceuticals Works Ltd in 2008 and later, in 2015, acquired the business of Kesh King, entering the Ayurvedic hair and scalp care segment.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.